logo

INSMED | Sustainability & Chart

US4576693075

Basic information on INSMED

Location: United States

Industry: Health Services

Website

knob-globe
52%

Impact Score

Description INSMED

Insmed Inc. is a global biopharmaceutical company focused on developing therapies for patients suffering from serious and rare diseases, including those affecting the lungs.

INSMED Sustainability Performance

Renewable Energy
Greenhouse Gas Emissions
Supply Chain
Waste Recycling
Sustainable [100]
Almost sustainable [67-99]
Moderate [34-66]
Not sustainable [0-33]
No data
We measure the sustainability of companies based on 12 criteria.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). Learn more about our method.

Compare INSMED with ...

INSMED

?

Impact Score

knob-globe
52%
knob-globe
0%
Climate
Society
Gender

Sources of sustainability performance

MetricValueUnitYearPDF NamePDF Page
CEO Pay Ratio
CEO nameWilliam H. Lewis2025sec-def-14a-2025-remuneration-report.pdf14
CEO-to-median-salary-ratio50,85Ratio2025sec-def-14a-2025-remuneration-report.pdf66
Employee Turnover Rate
Voluntary employee turnover3%2025Insmed-2025-ResponsibilityReport.pdf21
Glass Ceiling
Women in workforce56%2025Insmed-2025-ResponsibilityReport.pdf22
Women in management31%2025Insmed-2025-ResponsibilityReport.pdf22
Greenhouse Gas Emissions
Scope 2 emissions, location based2 264MTCO2e2025Insmed-2025-ResponsibilityReport.pdf27
Scope 1 emissions2 622MTCO2e2025Insmed-2025-ResponsibilityReport.pdf27
Number of employees1 663people2025sec-def-14a-2025-remuneration-report.pdf66
Harassment and Discrimination at the Workplace
Retaliation safeguardsYes2025Code-of-Business-Conduct-and-Ethics.pdf10
Confidentiality mechanismsYes2025Code-of-Business-Conduct-and-Ethics.pdf10
Incident notification mechanismYes2025sec-def-14a-2025-remuneration-report.pdf20
Anti-discrimination policyYes2025Code-of-Business-Conduct-and-Ethics.pdf20
Renewable Energy
Total renewable energy consumption19%2025Insmed-2025-ResponsibilityReport.pdf28
Supply Chain
Scope 3 emissions96 057MTCO2e2025Insmed-2025-ResponsibilityReport.pdf27
Number of employees1 663people2025sec-def-14a-2025-remuneration-report.pdf66
Scope 2 emissions, location based2 264MTCO2e2025Insmed-2025-ResponsibilityReport.pdf27
Scope 1 emissions2 622MTCO2e2025Insmed-2025-ResponsibilityReport.pdf27
Union Formation and Collective Bargaining Power
Number of employees1 663people2025sec-def-14a-2025-remuneration-report.pdf66
Collective bargaining agreements coverage0#2025sec-10-k-2025-annual-report.pdf35
Women on Board
Supervisory board size7people2025Insmed-2025-ResponsibilityReport.pdf31
Women on supervisory board3people2025Insmed-2025-ResponsibilityReport.pdf31
Executive board size6people2025sec-def-14a-2025-remuneration-report.pdf35
Women on executive board3people2025sec-def-14a-2025-remuneration-report.pdf35
Women in Management
Women in management31%2025Insmed-2025-ResponsibilityReport.pdf22
Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.

Find more sustainable companies

logo
© 2026 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The source of ETF data is the websites and data sheets of the respective ETF providers.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support!Logos provided by Logo.dev